ARTICLE | Distillery Therapeutics
Therapeutics: Vascular endothelial growth factor B (VEGF-B); vascular endothelial growth factor receptor 1 (FLT1; VEGFR-1)
April 21, 2016 7:00 AM UTC
Mouse studies suggest that promoting VEGF-B and inhibiting FLT1 could help treat metabolic syndrome and obesity. In a mouse model of metabolic syndrome, systemic viral vector-mediated VEGF-B expressio...